Skip to main content


Icon Legend
Presentation Icons
Platinum Award
Platinum Award
Gold Award
Gold Award
Silver Award
Silver Award
Bronze Award
Bronze Award

  • Thursday, Nov 16th
    10:15 AM - 11:45 AM MST
    Economic Challenges of Delivering Molecular Diagnostics for Patients: PAMA, New Codes, and Prior AuthorizationEconomic Challenges of Delivering Molecular Diagnostics to Patients focusing on PAMA, New Codes, and Prior Authorization
    Location: 250, Upper Concourse
    Moderator: Jay Patel – ARUP Laboratories
    Advocacy
     CE: 1.50
  • Thursday, Nov 16th
    10:15 AM - 11:45 AM MST
    Polygenic Risk Scores - Implementation and Clinical Utility
    Location: 255EF, Second Level
    Co-Moderator: Honey Reddi, PhD – Medical College of Wisconsin
    Co-Moderator: Meng-Chang Hsiao, PhD – Vanderbilt University Medical Center
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    10:20 AM - 10:45 AM MST
    Addressing Protecting Access to Medicare Act (PAMA) Its History, Challenges, and Current Legislative Status
    Location: 250, Upper Concourse
    Speaker: Samuel K. Caughron, MD – MAWD Pathology
    Advocacy
     CE: 1.50
  • Thursday, Nov 16th
    10:45 AM - 11:10 AM MST
    CPT Coding Developments for Molecular Pathology Procedures and Their Impacts on the Field at Large
    Location: 250, Upper Concourse
    Speaker: Aaron D. Bossler, MD, PhD – University of Iowa
    Advocacy
     CE: 1.50
  • Thursday, Nov 16th
    10:45 AM - 11:15 AM MST
    Implementation of Polygenic Risk Scores - Laboratory Perspectives
    Location: 255EF, Second Level
    Speaker: Matthew Lebo, PhD (he/him/his) – Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    11:10 AM - 11:35 AM MST
    The Current Landscape of Prior Authorization Procedures and Its Challenges
    Location: 250, Upper Concourse
    Advocacy
     CE: 1.50
  • Thursday, Nov 16th
    11:15 AM - 11:45 AM MST
    Status of the Use of Polygenic Scores for PGT
    Location: 255EF, Second Level
    Speaker: Patrick Turley, PhD (he/him/his) – University of Southern California
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    1:15 PM - 1:45 PM MST
    Newborn Screening by Genomic Sequencing: Opportunities and Challenges
    Location: 355BC, Third Level
    Speaker: Wendy Chung, MD, PhD (she/her/hers) – Boston Children's Hospital/Harvard Medical School
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    1:15 PM - 2:00 PM MST
    AMP Advocacy: Celebrating the Past and Looking Towards the Future - Panel Discussion
    Location: 250, Upper Concourse
    Panelist: Mary Steele Williams, MNA (she/her/hers) – Association for Molecular Pathology
    Panelist: Roger Klein, MD, JD – Roger D. Klein, MD JD Consulting
    Panelist: Jan Nowak, MD – Roswell Park Cancer Institute
    Panelist: Paul Diaz – CEO of Myriad Genetics
    Panelist: Tania Simoncelli – Chan Zuckerberg Initiative
    Advocacy
     CE: NOT CME/CMLE
  • Friday, Nov 17th
    1:45 PM - 2:15 PM MST
    Adding Genomic Sequencing and Genetic Risk Scores to the Early Check Newborn Screening Study
    Location: 355BC, Third Level
    Speaker: Katerina S. Kucera, PhD – RTI International
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    2:00 PM - 2:15 PM MST
    AMP Advocacy: Celebrating the Past and Looking Towards the Future
    Location: 250, Upper Concourse
    Moderator: Jennifer Leib, ScM (she/her/hers) – Innovation Policy Solutions LLC
    Advocacy
     CE: NOT CME/CMLE
  • Friday, Nov 17th
    2:15 PM - 2:45 PM MST
    AMP Advocacy: Celebrating the Past and Looking Towards the Future
    Location: 250, Upper Concourse
    Speaker: Eric Q. Konnick, MD, MS (he/him/his) – University of Washington Department of Laboratory Medicine and Pathology
    Speaker: Karen Weck, MD (she/her/hers) – University of North Carolina at Chapel Hill
    Advocacy
     CE: NOT CME/CMLE
  • Friday, Nov 17th
    2:15 PM - 2:45 PM MST
    Exploring Whole Genome Sequencing for Newborn Screening: Lessons from the BabySeq Project
    Location: 355BC, Third Level
    Speaker: Matthew Lebo, PhD (he/him/his) – Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Saturday, Nov 18th
    10:15 AM - 10:45 AM MST
    AI/ML Pipeline to Identify Genetic Biomarkers and Predict Disease for Precision Medicine
    Location: 251, Upper Concourse
    Speaker: Zeeshan Ahmed, PhD (he/him/his) – Rutgers Institute for Health, Health Care Policy and Aging Research. Rutgers Robert Wood Johnson Medical School. Rutgers Biomedical and Health Sciences. Rutgers, The State University of New Jersey.
    AdvocacyInformatics
     CE: 1.50
  • Saturday, Nov 18th
    10:45 AM - 11:15 AM MST
    "Weakly-Supervised Tumor Purity Prediction from Frozen H&E Stained Slides"
    Location: 251, Upper Concourse
    Speaker: Iman Hajirasouliha, PHS (he/him/his) – WEII CORNELL MEDICINE
    AdvocacyInformatics
     CE: 1.50
  • Saturday, Nov 18th
    11:15 AM - 11:45 AM MST
    Approaches and Techniques to Consider when Building Machine Learning Models
    Location: 251, Upper Concourse
    AdvocacyInformatics
     CE: 1.50